Medicare CED Could Enhance Efficiency Of FDA Post-Approval Studies – CMS Draft Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
Medicare’s coverage with evidence development policy could help enhance the efficiency of research conducted under FDA post-approval requirements, CMS says in a draft guidance on CED released Nov. 29.